期刊
EUROPEAN JOURNAL OF CANCER
卷 42, 期 18, 页码 3095-3102出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2006.05.041
关键词
ubiquitin; multiple myeloma; leukaemia; lymphoma; bortezomib; Ub system-targeted drugs
类别
Ubiquitin (Ub) is a small protein modifier involved in cellular functions such as cell cycle, apoptosis, cell signalling, endocytosis, transcription and DNA repair. Ubiquitin operates as a reversible and highly versatile regulatory signal, which may be read and interpreted by an expanding number of Ub-binding domains (UBD). There is accumulating evidence that mutations or altered expression of ubiquitylating or de-ubiquitylating enzymes as well as of Ub-binding proteins affect crucial mediators of such functions and are found in several malignancies. Here we discuss how oncogenic alterations in the Ub system can be targeted by anti-cancer therapies. (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据